Tafamidis versus liver transplantation as first-line therapy for hereditary transthyretin amyloidosis

Back

ESC Premium Access

Tafamidis versus liver transplantation as first-line therapy for hereditary transthyretin amyloidosis

Session: Hot topics in myocardial and pericardial diseases

Topic: Infiltrative Myocardial Disease

Speaker: Doctor V. Algalarrondo (Paris, FR)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Vincent Algalarrondo

Hospital Bichat-Claude Bernard, Paris (France)

1 presentation

0 follower

8 more presentations in this session

Role of 18FDG(fluorodeoxyglucose)-PET (positron emission tomography) for differential diagnosis of pericardial disease

Speaker: Doctor C. Hyeon (Seoul, KR)

Interim analysis of data from a long-term, extension trial of tafamidis meglumine in patients with transthyretin amyloid cardiomyopathy

Speaker: Doctor S. Gottlieb (Baltimore, US)

Myocardial perfusion mapping in cardiac amyloidosis- exploring the spectrum from infiltration to ischaemia

Speaker: Doctor T. Kotecha (London, GB)

The increased serum level of troponin T after immunosuppression therapy reflects sustained myocardial FDG accumulation in cardiac sarcoidosis

Speaker: Doctor R. Morimoto (Nagoya, JP)

Anti-heart and anti-intercalated disk autoantibodies: possible novel biomarkers of cardiac sarcoidosis

Speaker: Professor A. Caforio (Padova, IT)

Access the full session

Hot topics in myocardial and pericardial diseases

Speakers: Doctor V. Algalarrondo, Doctor C. Hyeon, Doctor S. Gottlieb, Doctor T. Kotecha, Doctor R. Morimoto...

Access

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources